15,841 Astera Labs, Inc. $ALAB Shares Purchased by ProShare Advisors LLC

ProShare Advisors LLC boosted its stake in shares of Astera Labs, Inc. (NASDAQ:ALAB) by 9.4% during the 3rd quarter, according to its most recent 13F filing with the SEC. The firm owned 184,326 shares of the company’s stock after buying an additional 15,841 shares during the period. ProShare Advisors LLC owned approximately 0.11% of Astera Labs worth $65,615,000 at the end of the most recent quarter.

A number of other institutional investors also recently bought and sold shares of the stock. BlackRock Inc. bought a new position in Astera Labs during the second quarter valued at $6,609,581,000. Atreides Management LP lifted its holdings in shares of Astera Labs by 108.9% in the 1st quarter. Atreides Management LP now owns 3,365,787 shares of the company’s stock worth $368,890,000 after acquiring an additional 1,754,593 shares during the last quarter. Van ECK Associates Corp lifted its holdings in shares of Astera Labs by 20.0% in the 2nd quarter. Van ECK Associates Corp now owns 2,237,961 shares of the company’s stock worth $1,080,980,000 after acquiring an additional 373,545 shares during the last quarter. Bank of America Corp DE bought a new stake in shares of Astera Labs in the 2nd quarter worth about $1,061,791,000. Finally, Amundi boosted its stake in shares of Astera Labs by 77.9% during the 1st quarter. Amundi now owns 1,880,830 shares of the company’s stock worth $206,139,000 after purchasing an additional 823,477 shares during the period. 60.47% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

Several brokerages recently commented on ALAB. TD Cowen cut their price target on shares of Astera Labs from $375.00 to $300.00 and set a “hold” rating on the stock in a report on Monday, October 19th. Northland Securities downgraded shares of Astera Labs from an “outperform” rating to a “market perform” rating in a research note on Friday, October 9th. UBS Group restated a “neutral” rating and set a $425.00 target price on shares of Astera Labs in a research report on Wednesday, August 5th. Zacks Research cut Astera Labs from a “strong-buy” rating to a “hold” rating in a research note on Monday, October 5th. Finally, Weiss Ratings cut Astera Labs from a “buy (b-)” rating to a “hold (c)” rating in a research note on Friday, October 23rd. Eleven research analysts have rated the stock with a Buy rating and eleven have issued a Hold rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $340.79.

Insiders Place Their Bets

In other Astera Labs news, CEO Jitendra Mohan sold 90,630 shares of the company’s stock in a transaction dated Monday, August 17th. The shares were sold at an average price of $340.35, for a total value of $30,845,920.50. Following the transaction, the chief executive officer directly owned 1,266,665 shares in the company, valued at $431,109,432.75. This represents a 6.68% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, General Counsel Philip Mazzara sold 6,801 shares of the firm’s stock in a transaction that occurred on Monday, August 17th. The stock was sold at an average price of $340.50, for a total transaction of $2,315,740.50. Following the transaction, the general counsel directly owned 96,542 shares in the company, valued at approximately $32,872,551. This trade represents a 6.58% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last three months, insiders sold 408,558 shares of company stock worth $127,306,034. 10.40% of the stock is owned by company insiders.

Astera Labs Stock Performance

Shares of ALAB opened at $258.70 on Monday. The firm has a market capitalization of $44.88 billion, a P/E ratio of 128.07 and a beta of 3.68. Astera Labs, Inc. has a 12-month low of $97.89 and a 12-month high of $499.48. The firm has a fifty day moving average price of $308.12 and a 200-day moving average price of $254.98.

Astera Labs (NASDAQ:ALAB) last posted its quarterly earnings results on Tuesday, August 4th. The company reported $0.80 EPS for the quarter, topping analysts’ consensus estimates of $0.69 by $0.11. Astera Labs had a net margin of 30.74% and a return on equity of 19.24%. The firm had revenue of $392.40 million for the quarter, compared to analysts’ expectations of $360.85 million. During the same period in the prior year, the business posted $0.44 earnings per share. The business’s revenue for the quarter was up 104.5% on a year-over-year basis. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. Analysts predict that Astera Labs, Inc. will post 2.71 earnings per share for the current year.

About Astera Labs

Astera Labs, Inc is a semiconductor and connectivity solutions company that develops hardware and software for data centers, cloud computing, and artificial intelligence infrastructure. Its products are designed to help move data between processors, memory, storage, and networking components while addressing bandwidth, latency, and system-management requirements.

The company’s portfolio includes Aries PCI Express and Compute Express Link (CXL) Smart Retimers, Taurus Ethernet Smart Cable Modules, Scorpio Smart Fabric Switches, and Leo CXL Memory Connectivity Controllers.